Učitavanje...
Designer receptor technology for the treatment of epilepsy
Epilepsy remains refractory to medical treatment in ~30% of patients despite decades of new drug development. Neurosurgery to remove or disconnect the seizure focus is often curative but frequently contraindicated by risks of irreversible impairment to brain function. Novel therapies are therefore r...
Spremljeno u:
| Izdano u: | EBioMedicine |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Elsevier
2019
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6558262/ https://ncbi.nlm.nih.gov/pubmed/31078519 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2019.04.059 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|